| Quarterly Financials | Mar 2016 | Jun 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 |
Revenue  | 0 | 0 | 3 | 12 | 6 | 5 | 0 | 6 | 15 | 17 | 17 | 9 | 7 | 10 |
| Expenses | 0 | 0 | 2 | 11 | 6 | 5 | 1 | 5 | 15 | 17 | 17 | 9 | 6 | 10 |
| EBITDA | 0 | -0 | 1 | 1 | 0 | 0 | -0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 |
| Operating Profit % | 0 % | 0 % | 26 % | 7 % | 1 % | 1 % | -50 % | 7 % | 2 % | 1 % | -5 % | 2 % | 3 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 1 | 1 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -0 | 1 | 1 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| EPS in ₹ | 0.00 | -0.53 | 0.90 | 1.12 | -0.23 | -0.19 | -0.70 | 0.62 | 0.46 | 0.24 | -1.21 | 0.21 | 0.15 | -0.07 |
Prism Medico & Pharmacy
Prism Medico & Pharmacy
21.25
+0.97
(4.78%)
Key Fundamentals
Market Cap
12.30 Cr
EPS
0.07
PE Ratio
18.13
Dividend Yield
0.00 %
Industry
Financial Services 52 Week High
29.98
52 Week Low
11.62
PB Ratio
0.84
Debt to Equity
0.17
Sector
NBFC Actual
Company News
View All News
Prism Medico and Pharmacy Limited Reports Strong Quarterly Performance with 65.73 Lakh Net Profit
Sep 12, 2025
Sep 12, 2025Prism Medico and Pharmacy Limited's Board of Directors approved unaudited standalone financial results for the quarter ended June 30, 2025. The company reported revenue from operations of 158.87 lakhs, a significant increase from 7.28 lakhs in the previous quarter and 6.27 lakhs in the corresponding quarter last year. Net profit for the quarter reached 65.73 lakhs, compared to 4.15 lakhs in the previous quarter and a loss of 9.00 lakhs in the year-ago period. Total expenses were 93.84 lakhs, with cost of materials consumed being the largest component at 85.75 lakhs. The company's earnings per share improved to 0.0108 rupees from 0.0007 rupees in the previous quarter. The paid-up equity share capital remained stable at 606.34 lakhs. The results were reviewed by auditors Garg Mendiratta & Associates and approved by the Board at a meeting held on August 14, 2025.
Prism Medico and Pharmacy Reports Strong Quarterly Results with 65.73 Lakh Net ProfitAug 14, 2025
Prism Medico and Pharmacy Limited's Board approved unaudited standalone financial results for the quarter ended June 30, 2025. The company reported revenue from operations of 158.87 lakhs, significantly higher than 7.28 lakhs in the previous quarter and 6.27 lakhs in the year-ago period. Net profit reached 65.73 lakhs compared to 4.15 lakhs in the previous quarter and a loss of 9.00 lakhs in the corresponding quarter last year. Total expenses were 93.84 lakhs, with cost of material consumed being the largest component at 85.75 lakhs. The company's earnings per share improved to 0.0108 from 0.0007 in the previous quarter. The paid-up equity share capital remained stable at 606.34 lakhs. The results were reviewed by auditors Garg Mendiratta & Associates and approved by the Board on August 14, 2025.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,070.10 | #1 6,63,161.00 | 37.76 | #1 69,724.80 | 26.81 | #1 16,780 | 21.81 | 71.32 | |
309.30 | 1,98,281.60 | 120.35 | 2,078.90 | 12.09 | 1,613 | 0.86 | 50.76 | |
1,654.30 | 1,40,353.80 | 31.34 | 26,152.80 | 34.67 | 4,260 | 20.12 | 58.81 | |
3,334.50 | 1,31,220.00 | 21.82 | 20,324.50 | 34.04 | 5,352 | 65.12 | 73.53 | |
675.50 | 1,26,497.80 | 13.09 | 41,859.50 | 19.61 | 9,423 | 6.34 | 66.53 | |
927.00 | 88,955.10 | 46.95 | 18,637.10 | 6.60 | 1,916 | -6.48 | 66.54 | |
3,162.20 | 54,994.10 | 13.17 | 4,612.20 | #1 76.63 | 4,241 | -14.01 | 50.72 | |
4,488.20 | 49,892.30 | 25.97 | 8,563.00 | 17.53 | 1,813 | 9.27 | 49.29 | |
526.40 | 41,017.50 | #1 -130.57 | 4,222.80 | 34.17 | -98 | #1 115.75 | 59.74 | |
300.10 | 40,767.90 | 18.24 | 18,530.50 | 16.03 | 2,261 | 6.44 | 71.07 |
Growth Rate
Revenue Growth
139.91 %
Net Income Growth
1,057.14 %
Cash Flow Change
-112.39 %
ROE
-1,133.33 %
ROCE
-97.09 %
EBITDA Margin (Avg.)
-79.55 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 |
| Total Assets | 17 | 16 | 21 |
| Fixed Assets | 10 | 9 | 9 |
| Current Assets | 7 | 4 | 11 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 3 | 1 |
| Other Assets | 7 | 4 | 11 |
| Total Liabilities | 17 | 16 | 21 |
| Current Liabilities | 1 | 3 | 8 |
| Non Current Liabilities | 3 | 0 | 0 |
| Total Equity | 13 | 13 | 13 |
| Reserve & Surplus | 7 | 7 | 7 |
| Share Capital | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 |
| Net Cash Flow | 0 | -1 | -1 |
| Investing Activities | 0 | -3 | 0 |
| Operating Activities | 0 | 4 | -0 |
| Financing Activities | 0 | -2 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 38.02 % | 29.06 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 54.60 % | 59.85 % | 69.11 % | 68.82 % | 67.22 % | 67.65 % | 64.91 % | 64.89 % | 61.78 % | 63.66 % | 64.02 % | 65.76 % | 67.23 % | 67.30 % | 65.77 % | 65.36 % | 66.07 % | 65.26 % |
| Others | 7.38 % | 11.09 % | 6.95 % | 7.25 % | 8.85 % | 8.42 % | 11.16 % | 11.18 % | 14.29 % | 11.34 % | 10.98 % | 9.24 % | 7.77 % | 7.70 % | 9.23 % | 9.64 % | 8.93 % | 9.74 % |
| No of Share Holders | 1,243 | 1,900 | 2,790 | 3,731 | 4,245 | 4,168 | 3,890 | 3,328 | 3,558 | 3,610 | 3,465 | 3,650 | 3,792 | 3,866 | 4,107 | 4,178 | 4,302 | 4,306 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 May 2018 |  Change Of Name | NA | 30 May 2018 | 25.50 | 25.50 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 34.88 | 29.91 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 26.51 | 27.05 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 17.28 | 16.68 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 14.68 | 16.65 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 13.75 | 13.84 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 17.85 | 21.43 |
Announcements
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.2 days ago
2 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20186 days ago
6 days agoShareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Compliance-57 (5) : intimation after the end of quarterOct 01, 2025
Oct 01, 2025Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 01, 2025
Oct 01, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 23Rd Annual General Meeting Held On 30Th September 2025.Sep 30, 2025
Sep 30, 2025Outcome Of 23Rd Annual General Meeting Held On 30Th September 2025 At 11:30 A.M. Through Video Conferencing/Other Audio Visual Means.Sep 30, 2025
Sep 30, 2025Revised Outcome Of Board Meeting Dated 14Th August 2025.Sep 12, 2025
Sep 12, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Intimation Of Record Date.Sep 05, 2025
Sep 05, 2025Intimation Of Book Closure.Sep 05, 2025
Sep 05, 2025Notice Of 23Rd Annual General Meeting.Sep 05, 2025
Sep 05, 2025Annual Report For The Financial Year 2024-2025.Sep 05, 2025
Sep 05, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 05, 2025
Sep 05, 2025Board Meeting Intimation for Intimation Of Board Meeting.Sep 01, 2025
Sep 01, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 07, 2025
Aug 07, 2025Board Meeting Intimation for Meeting To Be Held On Thursday The 14Th Day Of August 2025 At 01:30 P.M. At The Registered Office Of The Company I.E. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030.Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 04, 2025
Aug 04, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 16, 2025
Jul 16, 2025Undertaking Of Functional Website.Jul 15, 2025
Jul 15, 2025Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jul 15, 2025
Jul 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Revised Outcome Of Board Meeting Dated 28Th May 2025.Jul 01, 2025
Jul 01, 2025Compliance-57 (5) : intimation after the end of quarterJul 01, 2025
Jul 01, 2025Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Details Of Related Party Transactions (RPTS) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 28, 2025
May 28, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 28, 2025
May 28, 2025Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.May 20, 2025
May 20, 2025Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2025.Apr 25, 2025
Apr 25, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Apr 15, 2025
Apr 15, 2025Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework.Apr 09, 2025
Apr 09, 2025Submission Of Compliance Certificate As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 During The Financial Year Ended 31St March 2025.Apr 09, 2025
Apr 09, 2025Undertaking Of Functional Website.Apr 09, 2025
Apr 09, 2025Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For The Financial Year Ended 31St March 2025.Apr 08, 2025
Apr 08, 2025Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Apr 07, 2025
Apr 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Compliance-57 (5) : intimation after the end of quarterApr 01, 2025
Apr 01, 2025Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 31, 2025
Mar 31, 2025Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 14, 2025
Feb 14, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 14, 2025
Feb 14, 2025Board Meeting Intimation for INTIMATION OF BOARD MEETINGFeb 07, 2025
Feb 07, 2025Undertaking Of Functional Website.Jan 21, 2025
Jan 21, 2025Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 18, 2025
Jan 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Jan 14, 2025Closure of Trading WindowDec 31, 2024
Dec 31, 2024Details Of Related Party Transactions (RPT'S) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Nov 14, 2024
Nov 14, 2024Technical Indicators
RSI(14)
Neutral 54.58
ATR(14)
Volatile 1.28
STOCH(9,6)
Neutral 44.54
STOCH RSI(14)
Oversold 10.76
MACD(12,26)
Bearish -0.17
ADX(14)
Strong Trend 25.56
UO(9)
Bearish 59.04
ROC(12)
Downtrend And Accelerating -7.33
WillR(14)
Neutral -68.10
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
